Global Biopreservation Market

Biopreservation Market Size, Share, Growth Analysis, By Product(Equipment, Media, and Laboratory Information Management System (LIMS)), By Application(Regenerative Medicine, Bio-banking, and Drug Discovery), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2223 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 63 | Figures: 75

Biopreservation Market Dynamics

Biopreservation Market Drivers

Prevalence of Chronic Disease  

  • Reported chronic diseases cases are on the rise globally. In developed economies such as the US chronic disease was reported annually in more than 30% of the adult population while in developing economies such as India, chronic diseases were reported in more than 23% of the adult population. Chronic diseases have high requirement of diagnosis and other alternate therapies thus boosting the demand for biopreservation. 

Growing Demand for Regenerative Medicines and Treatment  

  • Advancements in cell therapy, molecular technology, tissue engineering, gene therapy, and regenerative medicines have gained significant traction is the last decade. In terms of revenue growth regenerative medicines are witnessing double digits growth figures and this trend is expected to continue during the forecast period thus boosting the demand for biopreservation considerably. 

Restraints 

High Cost of Preservation  

  • Biopreservation is made possible by controlling temperature, pressure, pH and other physical factors based on the stability of the biomass being stored. These require advanced equipment, consumables, media solutions and skilled personnel. In addition, some of the consumables are highly instable and are also not widely available. The cost of initial investment is significantly high resulting in restricted wider applications.  

Lack of Skilled Workforce  

  • Biopreservation is a relatively new technology, and its work force required is not aptly trained. Application areas of biopreservation such as cell therapy and genetic engineering are also relatively new sciences, and the work force is yet to be skilled in these areas. With the increasing government spending on education and healthcare, the workforce is expected to be skilled in the long term, but this factor is expected to be constrained in the short to medium term.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Biopreservation Market size was valued at USD 2.18 billion in 2022 and is poised to grow from USD 2.80 billion in 2023 to USD 20.54 billion by 2031, growing at a CAGR of 28.30% during the forecast period (2024-2031).

Biopreservation market is capital and innovation extensive hence it is dominated by large multinational companies. There is a higher degree of collaboration between the government and private sector in terms of research and funding. Government regulations are also on the higher side in the market, and they vary for each geography. Hence, companies with wider regional outreach have a competitive edge.  'Thermo Fisher Scientific Inc.', 'Merck KGaA', 'BioLife Solutions, Inc.', 'GE Healthcare', 'VWR International LLC', 'Custom Biogenic Systems, Inc.', 'Chart Industries, Inc.', 'BioCision LLC', 'STEMCELL Technologies Inc.', 'Cesca Therapeutics Inc.', 'Core Dynamics Ltd.', 'Panasonic Healthcare Co., Ltd.', 'Avantor, Inc.', 'Lonza Group Ltd.', 'Brooks Automation, Inc.', 'BioStorage Technologies, Inc.', 'LabVantage Solutions, Inc.', 'Atlanta Biologicals, Inc.', 'Hamilton Company', 'So-Low Environmental Equipment Co.'

Reported chronic diseases cases are on the rise globally. In developed economies such as the US chronic disease was reported annually in more than 30% of the adult population while in developing economies such as India, chronic diseases were reported in more than 23% of the adult population. Chronic diseases have high requirement of diagnosis and other alternate therapies thus boosting the demand for biopreservation. 

Increasing Investment on Research and Development: Cell therapy and genetic engineering demand is expected to witness more than 30% CAGR during the forecast period. This is attracting investment from biomedical companies for research and development. Cell and gene therapy is transforming the diagnosis and treatment of critical patients and chronic diseases. Government spending on research centers focusing on gene therapy and regenerative treatment is also expected to grow. 

North America dominated the market and accounted for highest market share in 2023, driven by flourishing healthcare sector and growing budget for pharmaceutical research. US accounts for the largest market for clinical trials of new drugs and is the powerhouse of drug discovery. The presence of research centers of large pharmaceutical companies and world class healthcare providers creates high demand for biopreservation of samples required in treatment and research. In addition, the number of cases of chronic disease is significantly high and acceptance of personalized medication using regenerative techniques is also significantly more mature in North America especially in the US. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Biopreservation Market

Report ID: SQMIG35I2223

$5,300
BUY NOW GET FREE SAMPLE